Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Retatrutide Investigational triple hormone receptor agonist (GIP/GLP-1/Glucagon) educational resource for qualified metabolic health research inquiries
Emerging data from meta-analyses, subgroup analyses, and observational studies suggest possible additive benefits of combination therapy
Cranial Magnetic Resonance Imaging Findings in Hypotonic Infants with Cobalamin Deficiency and Combined Methylmalonic Aciduria and Homocystinuria
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus
US$ 24.88
US$ 21.74
US$ 22.76
US$ 26.18
US$ 22.38
US$ 20.70
US$ 24.41
US$ 23.77
US$ 24.29
